Navigation Links
U.S. FDA Grants Priority Review to Bayer's Radium Ra 223 Dichloride NDA for Castration-Resistant Prostate Cancer with Bone Metastases
Date:2/12/2013

WAYNE, N.J., Feb. 13, 2013 /PRNewswire/ -- Bayer HealthCare announced today that the New Drug Application (NDA) for its investigational oncology compound Radium Ra 223 Dichloride (radium-223) has been accepted for filing and granted priority review by the U.S. Food and Drug Administration (FDA). The application is currently under review for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.

"We are pleased the FDA has granted priority review of the radium-223 new drug application for the treatment of patients with castration-resistant prostate cancer that has metastasized to the bones. Receiving this designation marks another positive milestone for radium-223 and underscores Bayer's ongoing commitment in oncology," stated Pamela A. Cyrus , MD, Vice President and Head of U.S. Medical Affairs, Bayer HealthCare Pharmaceuticals.

The FDA grants priority review to medicines that provide a treatment where little or no adequate therapy exists. Under the Prescription Drug User Fee Act (PDUFA), the FDA aims to complete its review within six months of the 60-day filing receipt of the NDA submission (eight months total), rather than the standard 12-month review cycle. 

In September 2009, Bayer signed an agreement with Algeta ASA (Oslo, Norway) for the development and commercialization of radium-223. Under the terms of the agreement, Bayer will develop, apply for health authority approvals worldwide, and commercialize radium-223 globally. Algeta will co-promote radium-223 with Bayer in the U.S.

About Radium Ra 223 Dichloride

Radium Ra 223 dichloride (radium-223), formerly referred to as radium-223 chloride, is an investigational alpha particle-emitting pharmaceutical in development for CRPC patients with bone metastases.

Radium-223 is an investigational agent and is not approved by the FDA, the Europe
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Afraxis Grants Exclusive Global License to Genentech
2. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
3. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
4. Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
5. New Jersey Health Foundation Commits $2 Million to Fund Grants
6. FDA Grants Orphan Drug Status To Morphoteks Amatuximab (MORAb-009)
7. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
8. ViiV Healthcare commits nearly £4M in Positive Action for Children Fund grants for programmes focused on alleviating burden of HIV on women and children
9. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
10. As Global Telemedicine Market Reaches $2.5 Billion, Industry Leaders Gather in San Diego to Discuss Grants, Funding, Vendor Selection, Credentialing, and More
11. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... of the "The Corporate Reputation of Pharma ... Edition " report to their offering. ... Perspective, is now in its fourth edition. This ... early 2015). For each annual Corporate Reputation report, ...
(Date:4/17/2015)... 17, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), a ... innovative therapeutics for the treatment of cancer and diseases ... of data from three of its most advanced oncology ... (AACR) 106 th Annual Meeting being held from ... USA. The presentation on the ...
(Date:4/16/2015)... China , April 16, 2015 ... leading developer, manufacturer, and marketer of medical devices ... the Securities and Exchange Commission an Annual Report on ... the year ended December 31, 2014. An electronic version ... available on Mindray,s investor relations website at  http://ir.mindray.com ...
Breaking Medicine Technology:The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2
... Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, ... or "AOBO"), a pharmaceutical company dedicated to improving ... a broad range of prescription and over-the-counter ("OTC") ... Wujia Rongxue Oral Liquid, ("AWRO Liquid"), an OTC ...
... Nov. 11, 2010 Misonix, Inc. (Nasdaq: ... ultrasonic medical device technology, which worldwide is used for ... quarter ended September 30, 2010 financial results on Monday, ... Executive Officer and Richard Zaremba, Senior VP and Chief ...
Cached Medicine Technology:American Oriental Bioengineering Introduces Wujia Rongxue Oral Liquid 2Misonix Schedules First Quarter 2011 Financial Results Conference Call; November 15, 2010 at 4:30 P.M. Eastern 2
(Date:4/19/2015)... Family and friends of Brad Baddeley are ... of Brad Baddeley event to honor his memory and ... for Brains is cheduled to take place on Sunday, April ... Lincoln, Nebraska. Participants may arrive at 12:30pm on the 26th ... cost is only $4 per game and 100% of the ...
(Date:4/18/2015)... NY (PRWEB) April 19, 2015 The ... strong growth during the past five years. The industry, ... who are unable to fully care for themselves, has ... growing need for dementia care for seniors with memory ... rise at an annualized rate of 4.1% to $1.9 ...
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog post ... during Spring. , Spring can be a great ... make sure they compare the newest policies before deciding ... more about Spring car insurance offers by reading the ... are becoming more and more popular. Many insurance brokerage ...
(Date:4/18/2015)... 2015 "I wanted to live ... a healthful juice that contained essential vitamins, minerals ... "It increases my energy, improves skin elasticity and ... developed Tapp's Juice to contain fruits, vegetables and ... physical and mental fatigue. It features a great ...
(Date:4/18/2015)... 2015 Lowcostcarinsuranceprice.com has released a new ... on auto insurance prices . , Drivers ... vehicle theft may have to pay more for auto ... insurance policies can also offer protection against vehicle theft. ... compared online on a single website: http://lowcostcarinsuranceprice.com/ ...
Breaking Medicine News(10 mins):Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2
... lower the age for prostate cancer detection in line with ... countries ahead of evidence from ongoing trials. In many countries, ... commences at 50 years, but a lower age limit has ... that found elevated prostate specific antigen (PSA) levels in men ...
... when a drug study was funded by the company that ... of that drug because the methods or analyses were manipulated. ... shows that, for blood pressure drugs, studies are now much ... have overly positive conclusions favouring the company,s products. , The ...
... supports home front needs of families with deployed Service members ... ... Healthcare Alliance will,present $30,000 to the Oregon National Guard,s Emergency Relief fund, which,will ... periods of deployment. "TriWest made the contribution with the hope that we ...
... With health care fraud,becoming more organized, sophisticated, ... insurance Special Investigative Units,(SIUs), state and federal ... the National Health Care Anti-Fraud Association (NHCAA),s ... California, to learn,more about new fraud schemes ...
... immunity , The prognosis for individuals with ... enhance the immune response have some clinical benefit; however, ... because their immune cells known as dendritic cells (DCs) ... response. New data generated in vitro using human melanoma ...
... BioHorizons Implant Systems,Inc. has introduced a new ... thread design and proven surface engineering technology. This,product ... the tapered,market segment which account for over 50% ... Internal Implants incorporate the Laser-Lok(R) precision,laser collar surface ...
Cached Medicine News:Health News:Should the UK lower the age for prostate cancer detection? 2Health News:Some drug studies more likely to have favorable conclusions 2Health News:TriWest Contributes $30,000 to Oregon National Guard Fund 2Health News:NHCAA Annual Training Conference Bringing Together Law Enforcement, Health Insurers to Fight Health Care Fraud 2Health News:NHCAA Annual Training Conference Bringing Together Law Enforcement, Health Insurers to Fight Health Care Fraud 3Health News:JCI table of contents: Nov. 15, 2007 2Health News:JCI table of contents: Nov. 15, 2007 3Health News:JCI table of contents: Nov. 15, 2007 4Health News:JCI table of contents: Nov. 15, 2007 5Health News:JCI table of contents: Nov. 15, 2007 6Health News:BioHorizons Introduces Its New Tapered Internal Implants Featuring Laser-Lok(R) Microgrooves 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: